The Crack Epidemic:
The Drug That Was Treated as a Crime

Crack cocaine — powder cocaine converted to a smokable form with baking soda and water — arrives in American cities around 1984. It is cheaper than powder cocaine, faster-acting, and produces a more intense but shorter-lasting high. For communities already devastated by deindustrialization, factory closings, and the gutting of social services under Reagan, the cheap, intense, immediately available high finds a market.

The drug devastates Black urban communities across the country. Addiction rates rise. Crack-related crime — particularly the violent competition between dealers for territory — contributes to murder rates in cities that reach historic highs in the late 1980s. Families are destroyed. Children are born to addicted mothers. The epidemic is real, not invented. The question is not whether crack was destructive — it clearly was — but whether the government's chosen response, mass incarceration, was appropriate, effective, or racially neutral. It was none of these things.

On June 19, 1986, college basketball star Len Bias — just drafted by the Boston Celtics — dies of a cocaine overdose. The drug in his system is powder cocaine. The legislation that bears his death's legacy is about crack. Within weeks, Congress passes the Anti-Drug Abuse Act of 1986, which mandates a minimum five-year federal prison sentence for possession of 5 grams of crack cocaine — but requires 500 grams of powder cocaine for the same sentence. The same drug. A 100:1 ratio. No pharmacological basis. No evidentiary hearing. No testimony from scientists.

The racial impact is immediate and documented. Because crack was predominantly used in Black communities and powder cocaine predominantly in white communities, 82% of federal crack defendants are Black. A Black person caught with 5 grams of crack gets the same sentence as a white person caught with 500 grams of powder. The Sentencing Commission — the official federal body responsible for sentencing policy — recommends equalizing the ratio four separate times. Congress overrides it each time.

Beginning in the late 1990s and accelerating through the 2000s and 2010s, a prescription opioid epidemic devastates largely white rural and suburban communities across the Midwest and Appalachia. Pharmaceutical companies — particularly Purdue Pharma — aggressively market OxyContin to doctors. Addiction rates soar. Deaths accumulate. By 2017, opioids kill more Americans per year than crack cocaine ever did at its peak.

The government's response is entirely different. Presidents Bush and Obama direct public health responses. Congress passes the Comprehensive Addiction and Recovery Act (2016) — emphasizing treatment, not incarceration. Naloxone (an overdose reversal drug) is distributed. Governors declare public health emergencies. The New York Times, Washington Post, and national media cover the epidemic with sympathy, focusing on the humanity of the addicted — their family stories, their economic desperation, their victimhood at the hands of pharmaceutical companies.

The contrast with the crack coverage of the 1980s is stark and documented. Crack users were "crackheads." Opioid users are "people struggling with addiction." Crack demanded prison. Opioids demand treatment. The drug is different. The race of the primary victims is different. The policy response is different. This is not coincidence. It is the operating logic of a system that has always treated addiction as a crime when Black people have it and a disease when white people do.